.png)
Oncology ngs market by Technology and Application- Global Industry Analysis & Forecast to 2027
Published On : January 2021 Pages : 140 Category: Pharma & Healthcare Report Code : HC0114966
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Oncology ngs market By Technology (Whole Genome Sequencing, Whole Exome Sequencing, Targeted Sequencing & Resequencing) and Application (Hospitals, Clinics, Laboratories)- Global Industry Analysis & Forecast to 2027
Industry Outlook and Trend Analysis
The Oncology ngs market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period.Oncology ngsgenerate both quantitative and qualitative sequence data, equivalent to the data from Human Genome Project, in two weeks. Currently, there are several NGS platforms commercially available.NGS provide a road map of the normal human genome and a landscape of mutations in cancer genomes across many cancer types
Drivers and Restraints
Top-down and bottom-up approaches are used to validate the global Oncology ngs market and estimate the market size for company, regions segments, type segments and applications (end users). In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
Regional Insights
The data for 2021 is an estimate, based on the history data and the integrated view of industry experts, manufacturers, distributors and end users etc.
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- SouthAmerica
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Turkey
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
- Agilent
- Thermo Fisher Scientific
- Myriad Genetics
- Beijing Genomics Institute (BGI)
- Perkin Elmer, Inc.
- QiagenNV
- Partek, Inc.
- Pacific Bioscience, Inc.
- Foundation Medicine
- Oxford Nanopore Technologies Ltd.
- Paradigm Diagnostics, Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2021 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Oncology ngs market, ByTechnology, Estimates and Forecast, 2017-2027 ($Million)
o Whole Genome Sequencing
o Whole Exome Sequencing
o Targeted Sequencing & Resequencing
· Oncology ngs market, ByApplication, Estimates and Forecast, 2017-2027 ($Million)
o Hospitals
o Clinics
o Laboratories
· Oncology ngs market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Agilent
o Thermo Fisher Scientific
o Myriad Genetics
o Beijing Genomics Institute (BGI)
o Perkin Elmer, Inc.
o Qiagen NV
o Partek, Inc.
o Pacific Bioscience, Inc.
o Foundation Medicine
o Oxford Nanopore Technologies Ltd.
o Paradigm Diagnostics, Inc.
· Oncology ngs market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Oncology ngs market, By Country
o U.S. Oncology ngs market
o Canada Oncology ngs market
o Mexico Oncology ngs market
o Europe
§ Europe Oncology ngs market, By Country
o UK Oncology ngs market
o Germany Oncology ngs market
o France Oncology ngs market
o Russia Oncology ngs market
o Italy Oncology ngs market
o Rest of Europe Oncology ngs market
o Asia-Pacific
§ Asia-Pacific Oncology ngs market, By Country
o China Oncology ngs market
o Japan Oncology ngs market
o South Korea Oncology ngs market
o India Oncology ngs market
o Southeast Asia Oncology ngs market
o Rest of Asia-Pacific Oncology ngs market
o South America
§ South America Oncology ngs market
o Brazil Oncology ngs market
o Argentina Oncology ngs market
o Columbia Oncology ngs market
o Rest of South America Oncology ngs market
o Middle East and Africa
§ Middle East and Africa Oncology ngs market
o Saudi Arabia Oncology ngs market
o UAE Oncology ngs market
o Egypt Oncology ngs market
o Nigeria Oncology ngs market
o South Africa Oncology ngs market
o TurkeyOncology ngs market
o Rest of MEA Oncology ngs market
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Oncology Ngs Market, By Technology
5.1. Introduction
5.2. Global Oncology Ngs Revenue and Market Share by Technology (2017-2021)
5.2.1. Global Oncology Ngs Revenue and Revenue Share by Technology (2017-2021)
5.3. Whole Genome Sequencing
5.3.1. Global Whole Genome Sequencing Revenue and Growth Rate (2017-2021)
5.4. Whole Exome Sequencing
5.4.1. Global Whole Exome Sequencing Revenue and Growth Rate (2017-2021)
5.5. Targeted Sequencing & Resequencing
5.5.1. Global Targeted Sequencing & Resequencing Revenue and Growth Rate (2017-2021)
6. Oncology Ngs Market, By Applications
6.1. Introduction
6.2. Global Oncology Ngs Revenue and Market Share by Applications (2017-2021)
6.2.1. Global Oncology Ngs Revenue and Revenue Share by Applications (2017-2021)
6.3. Hospitals
6.3.1. Global Hospitals Revenue and Growth Rate (2017-2021)
6.4. Clinics
6.4.1. Global Clinics Revenue and Growth Rate (2017-2021)
6.5. Laboratories
6.5.1. Global Laboratories Revenue and Growth Rate (2017-2021)
7. Oncology Ngs Market, By Region
7.1. Introduction
7.2. Global Oncology Ngs Revenue and Market Share by Regions
7.2.1. Global Oncology Ngs Revenue by Regions (2017-2021)
7.3. North America Oncology Ngs by Countries
7.3.1. North America Oncology Ngs Revenue and Growth Rate (2017-2021)
7.3.2. North America Oncology Ngs Revenue (Million USD) by Countries (2017-2021)
7.3.3. United States
7.3.3.1. United States Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.4. Canada
7.3.4.1. Canada Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.3.5. Mexico
7.3.5.1. Mexico Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4. Europe Oncology Ngs by Countries
7.4.1. Europe Oncology Ngs Revenue and Growth Rate (2017-2021)
7.4.2. Europe Oncology Ngs Revenue (Million USD) by Countries (2017-2021)
7.4.3. Germany
7.4.3.1. Germany Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.4. France
7.4.4.1. France Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.5. UK
7.4.5.1. UK Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.6. Russia
7.4.6.1. Russia Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.7. Italy
7.4.7.1. Italy Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5. Asia-Pacific Oncology Ngs by Countries
7.5.1. Asia-Pacific Oncology Ngs Revenue and Growth Rate (2017-2021)
7.5.2. Asia-Pacific Oncology Ngs Revenue (Million USD) by Countries (2017-2021)
7.5.3. China
7.5.3.1. China Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.4. Japan
7.5.4.1. Japan Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.5. Korea
7.5.5.1. Korea Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.6. India
7.5.6.1. India Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6. South America Oncology Ngs by Countries
7.6.1. South America Oncology Ngs Revenue and Growth Rate (2017-2021)
7.6.2. South America Oncology Ngs Revenue (Million USD) by Countries (2017-2021)
7.6.3. Brazil
7.6.3.1. Brazil Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.4. Argentina
7.6.4.1. Argentina Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.5. Columbia
7.6.5.1. Columbia Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7. Middle East and Africa Oncology Ngs by Countries
7.7.1. Middle East and Africa Oncology Ngs Revenue and Growth Rate (2017-2021)
7.7.2. Middle East and Africa Oncology Ngs Revenue (Million USD) by Countries (2017-2021)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.5. Egypt
7.7.5.1. Egypt Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.6. Nigeria
7.7.6.1. Nigeria Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.7. South Africa
7.7.7.1. South Africa Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.8. Turkey
7.7.8.1. Turkey Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2021)
8. Company Profiles
8.1. Agilent
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Thermo Fisher Scientific
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Myriad Genetics
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Beijing Genomics Institute (BGI)
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. Perkin Elmer, Inc.
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Qiagen NV
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
8.7. Partek, Inc.
8.7.1. Business Overview
8.7.2. Service Portfolio
8.7.3. Strategic Developments
8.7.4. Financial Overview
8.8. Pacific Bioscience, Inc.
8.8.1. Business Overview
8.8.2. Service Portfolio
8.8.3. Strategic Developments
8.8.4. Financial Overview
8.9. Foundation Medicine
8.9.1. Business Overview
8.9.2. Service Portfolio
8.9.3. Strategic Developments
8.9.4. Financial Overview
8.10. Oxford Nanopore Technologies Ltd.
8.10.1. Business Overview
8.10.2. Service Portfolio
8.10.3. Strategic Developments
8.10.4. Financial Overview
8.11. Paradigm Diagnostics, Inc.
8.11.1. Business Overview
8.11.2. Service Portfolio
8.11.3. Strategic Developments
8.11.4. Financial Overview
9. Oncology Ngs Market Forecast (2022-2027)
9.1. Global Oncology Ngs Revenue (Millions USD) and Growth Rate (2022-2027)
9.2. Oncology Ngs Market Forecast by Regions (2022-2027)
9.2.1. North America Oncology Ngs Market Forecast (2022-2027)
9.2.1.1. United States Oncology Ngs Market Forecast (2022-2027)
9.2.1.2. Canada Oncology Ngs Market Forecast (2022-2027)
9.2.1.3. Mexico Oncology Ngs Market Forecast (2022-2027)
9.2.2. Europe Oncology Ngs Market Forecast (2022-2027)
9.2.2.1. Germany Oncology Ngs Market Forecast (2022-2027)
9.2.2.2. France Oncology Ngs Market Forecast (2022-2027)
9.2.2.3. UK Oncology Ngs Market Forecast (2022-2027)
9.2.2.4. Russia Oncology Ngs Market Forecast (2022-2027)
9.2.2.5. Italy Oncology Ngs Market Forecast (2022-2027)
9.2.2.6. Rest of Europe Oncology Ngs Market Forecast (2022-2027)
9.2.3. Asia-Pacific Oncology Ngs Market Forecast (2022-2027)
9.2.3.1. China Oncology Ngs Market Forecast (2022-2027)
9.2.3.2. Japan Oncology Ngs Market Forecast (2022-2027)
9.2.3.3. Korea Oncology Ngs Market Forecast (2022-2027)
9.2.3.4. India Oncology Ngs Market Forecast (2022-2027)
9.2.3.5. Southeast Asia Oncology Ngs Market Forecast (2022-2027)
9.2.3.6. Rest of Asia-Pacific Oncology Ngs Market Forecast (2022-2027)
9.2.4. South America Oncology Ngs Market Forecast (2022-2027)
9.2.4.1. Brazil Oncology Ngs Market Forecast (2022-2027)
9.2.4.2. Argentina Oncology Ngs Market Forecast (2022-2027)
9.2.4.3. Columbia Oncology Ngs Market Forecast (2022-2027)
9.2.4.4. Rest of South America Oncology Ngs Market Forecast (2022-2027)
9.2.5. Middle East and Africa Oncology Ngs Market Forecast (2022-2027)
9.2.5.1. Saudi Arabia Oncology Ngs Market Forecast (2022-2027)
9.2.5.2. United Arab Emirates Oncology Ngs Market Forecast (2022-2027)
9.2.5.3. Egypt Oncology Ngs Market Forecast (2022-2027)
9.2.5.4. Nigeria Oncology Ngs Market Forecast (2022-2027)
9.2.5.5. South Africa Oncology Ngs Market Forecast (2022-2027)
9.2.5.6. Turkey Oncology Ngs Market Forecast (2022-2027)
9.2.5.7. Rest of Middle East and Africa Oncology Ngs Market Forecast (2022-2027)
9.3. Oncology Ngs Market Forecast by Technology (2022-2027)
9.3.1. Oncology Ngs Forecast by Technology (2022-2027)
9.3.2. Oncology Ngs Market Share Forecast by Technology (2022-2027)
9.4. Oncology Ngs Market Forecast by Applications (2022-2027)
9.4.1. Oncology Ngs Forecast by Applications (2022-2027)
9.4.2. Oncology Ngs Market Share Forecast by Applications (2022-2027)
List of Tables
List of Tables and Figures:
Figure United States Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Canada Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Mexico Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Germany Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure France Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure UK Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Russia Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Italy Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Europe Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Korea Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Asia-Pacific Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Brazil Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Argentina Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Columbia Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of South America Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Saudi Arabia Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure United Arab Emirates Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Egypt Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Nigeria Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure South Africa Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Turkey Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Figure Rest of Middle East and Africa Oncology Ngs Revenue (Million USD) and Growth Rate (2017-2027)
Table Global Oncology Ngs Revenue and Revenue Share by Technology (2017-2019)
Figure Global Whole Genome Sequencing Revenue and Growth Rate (2017-2019)
Figure Global Whole Exome Sequencing Revenue and Growth Rate (2017-2019)
Figure Global Targeted Sequencing & Resequencing Revenue and Growth Rate (2017-2019)
Table Global Oncology Ngs Revenue and Revenue Share by Applications (2017-2019)
Figure Global Hospitals Revenue and Growth Rate (2017-2019)
Figure Global Clinics Revenue and Growth Rate (2017-2019)
Figure Global Laboratories Revenue and Growth Rate (2017-2019)
Table Global Oncology Ngs Revenue by Regions (2017-2019)
Figure North America Oncology Ngs Growth Rate (2017-2019)
Figure North America Oncology Ngs Revenue and Growth Rate (2017-2019)
Figure North America Oncology Ngs by Countries (2017-2019)
Figure North America Oncology Ngs Revenue (Million USD) by Countries (2017-2019)
Figure United States Oncology Ngs Growth Rate (2017-2019)
Figure United States Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Canada Oncology Ngs Growth Rate (2017-2019)
Figure Canada Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Mexico Oncology Ngs Growth Rate (2017-2019)
Figure Mexico Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Europe Oncology Ngs Growth Rate (2017-2019)
Figure Europe Oncology Ngs Revenue and Growth Rate (2017-2019)
Figure Europe Oncology Ngs by Countries (2017-2019)
Figure Europe Oncology Ngs Revenue (Million USD) by Countries (2017-2019)
Figure Germany Oncology Ngs Growth Rate (2017-2019)
Figure Germany Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure France Oncology Ngs Growth Rate (2017-2019)
Figure France Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure UK Oncology Ngs Growth Rate (2017-2019)
Figure UK Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Russia Oncology Ngs Growth Rate (2017-2019)
Figure Russia Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Italy Oncology Ngs Growth Rate (2017-2019)
Figure Italy Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Europe Oncology Ngs Growth Rate (2017-2019)
Figure Rest of Europe Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Ngs Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Ngs Revenue and Growth Rate (2017-2019)
Figure Asia-Pacific Oncology Ngs by Countries (2017-2019)
Figure Asia-Pacific Oncology Ngs Revenue (Million USD) by Countries (2017-2019)
Figure China Oncology Ngs Growth Rate (2017-2019)
Figure China Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Japan Oncology Ngs Growth Rate (2017-2019)
Figure Japan Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Korea Oncology Ngs Growth Rate (2017-2019)
Figure Korea Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure India Oncology Ngs Growth Rate (2017-2019)
Figure India Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Southeast Asia Oncology Ngs Growth Rate (2017-2019)
Figure Southeast Asia Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Oncology Ngs Growth Rate (2017-2019)
Figure Rest of Asia-Pacific Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South America Oncology Ngs Growth Rate (2017-2019)
Figure South America Oncology Ngs Revenue and Growth Rate (2017-2019)
Figure South America Oncology Ngs by Countries (2017-2019)
Figure South America Oncology Ngs Revenue (Million USD) by Countries (2017-2019)
Figure Brazil Oncology Ngs Growth Rate (2017-2019)
Figure Brazil Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Argentina Oncology Ngs Growth Rate (2017-2019)
Figure Argentina Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Columbia Oncology Ngs Growth Rate (2017-2019)
Figure Columbia Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of South America Oncology Ngs Growth Rate (2017-2019)
Figure Rest of South America Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Ngs Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Ngs Revenue and Growth Rate (2017-2019)
Figure Middle East and Africa Oncology Ngs by Countries (2017-2019)
Figure Middle East and Africa Oncology Ngs Revenue (Million USD) by Countries (2017-2019)
Figure Saudi Arabia Oncology Ngs Growth Rate (2017-2019)
Figure Saudi Arabia Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure United Arab Emirates Oncology Ngs Growth Rate (2017-2019)
Figure United Arab Emirates Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Egypt Oncology Ngs Growth Rate (2017-2019)
Figure Egypt Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Nigeria Oncology Ngs Growth Rate (2017-2019)
Figure Nigeria Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure South Africa Oncology Ngs Growth Rate (2017-2019)
Figure South Africa Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Turkey Oncology Ngs Growth Rate (2017-2019)
Figure Turkey Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Oncology Ngs Growth Rate (2017-2019)
Figure Rest of Middle East and Africa Oncology Ngs Revenue (Millions USD) and Growth Rate (2017-2019)
Table Agilent Oncology Ngs Financial Overview
Table Thermo Fisher Scientific Oncology Ngs Financial Overview
Table Myriad Genetics Oncology Ngs Financial Overview
Table Beijing Genomics Institute (BGI) Oncology Ngs Financial Overview
Table Perkin Elmer, Inc. Oncology Ngs Financial Overview
Table Qiagen NV Oncology Ngs Financial Overview
Table Partek, Inc. Oncology Ngs Financial Overview
Table Pacific Bioscience, Inc. Oncology Ngs Financial Overview
Table Foundation Medicine Oncology Ngs Financial Overview
Table Oxford Nanopore Technologies Ltd. Oncology Ngs Financial Overview
Table Paradigm Diagnostics, Inc. Oncology Ngs Financial Overview
Figure Global Oncology Ngs Revenue (Millions USD) and Growth Rate (2019-2027)
Table Oncology Ngs Market Forecast by Regions (2019-2027)
Figure North America Oncology Ngs Market Forecast (2019-2027)
Figure United States Oncology Ngs Market Forecast (2019-2027)
Figure Canada Oncology Ngs Market Forecast (2019-2027)
Figure Mexico Oncology Ngs Market Forecast (2019-2027)
Figure Europe Oncology Ngs Market Forecast (2019-2027)
Figure Germany Oncology Ngs Market Forecast (2019-2027)
Figure France Oncology Ngs Market Forecast (2019-2027)
Figure UK Oncology Ngs Market Forecast (2019-2027)
Figure Russia Oncology Ngs Market Forecast (2019-2027)
Figure Italy Oncology Ngs Market Forecast (2019-2027)
Figure Rest of Europe Oncology Ngs Market Forecast (2019-2027)
Figure Asia-Pacific Oncology Ngs Market Forecast (2019-2027)
Figure China Oncology Ngs Market Forecast (2019-2027)
Figure Japan Oncology Ngs Market Forecast (2019-2027)
Figure Korea Oncology Ngs Market Forecast (2019-2027)
Figure India Oncology Ngs Market Forecast (2019-2027)
Figure Southeast Asia Oncology Ngs Market Forecast (2019-2027)
Figure Rest of Asia-Pacific Oncology Ngs Market Forecast (2019-2027)
Figure South America Oncology Ngs Market Forecast (2019-2027)
Figure Brazil Oncology Ngs Market Forecast (2019-2027)
Figure Argentina Oncology Ngs Market Forecast (2019-2027)
Figure Columbia Oncology Ngs Market Forecast (2019-2027)
Figure Rest of South America Oncology Ngs Market Forecast (2019-2027)
Figure Middle East and Africa Oncology Ngs Market Forecast (2019-2027)
Figure Saudi Arabia Oncology Ngs Market Forecast (2019-2027)
Figure United Arab Emirates Oncology Ngs Market Forecast (2019-2027)
Figure Egypt Oncology Ngs Market Forecast (2019-2027)
Figure Nigeria Oncology Ngs Market Forecast (2019-2027)
Figure South Africa Oncology Ngs Market Forecast (2019-2027)
Figure Turkey Oncology Ngs Market Forecast (2019-2027)
Figure Rest of Middle East and Africa Oncology Ngs Market Forecast (2019-2027)
Figure Global Oncology Ngs Forecast by Technology (2019-2027)
Figure Global Oncology Ngs Market Share Forecast by Technology (2019-2027)
Figure Global Oncology Ngs Forecast by Technology (2019-2027)
Figure Global Oncology Ngs Forecast by Applications (2019-2027)
Figure Global Oncology Ngs Market Share Forecast by Applications (2019-2027)
Figure Global Oncology Ngs Forecast by Applications (2019-2027)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|